These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20708471)

  • 41. Results of intravenous regional anaesthesia with distal forearm application.
    Karalezli N; Karalezli K; Iltar S; Cimen O; Aydoğan N
    Acta Orthop Belg; 2004 Oct; 70(5):401-5. PubMed ID: 15587026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ice minimizes discomfort associated with injection of botulinum toxin type A for the treatment of palmar and plantar hyperhidrosis.
    Smith KC; Comite SL; Storwick GS
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S88-91. PubMed ID: 17241420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study.
    Campanati A; Bernardini ML; Gesuita R; Offidani A
    Eur J Dermatol; 2007; 17(1):52-4. PubMed ID: 17324828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of peripheral analgesic effect of low-dose morphine during intravenous regional anesthesia.
    Gupta A; Björnsson A; Sjöberg F; Bengtsson M
    Reg Anesth; 1993; 18(4):250-3. PubMed ID: 8398960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The analgesic effect of paracetamol when added to lidocaine for intravenous regional anesthesia.
    Sen H; Kulahci Y; Bicerer E; Ozkan S; Dagli G; Turan A
    Anesth Analg; 2009 Oct; 109(4):1327-30. PubMed ID: 19762765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS; Onwudike M
    Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improving botulinum toxin therapy for palmar hyperhidrosis: wrist block and technical considerations.
    de Almeida AR; Kadunc BV; de Oliveira EM
    Dermatol Surg; 2001 Jan; 27(1):34-6. PubMed ID: 11231239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
    Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K
    Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.
    Krogstad AL; Skymne A; Pegenius G; Elam M; Wallin BG
    Br J Dermatol; 2005 Feb; 152(2):329-33. PubMed ID: 15727647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does wrist nerve block influence the result of botulinum toxin A treatment in palmar hyperhidrosis?
    Hund M; Rickert S; Kinkelin I; Naumann M; Hamm H
    J Am Acad Dermatol; 2004 Jan; 50(1):61-2. PubMed ID: 14699366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of the effects of lidocaine, lidocaine plus tramadol and lidocaine plus morphine for intravenous regional anesthesia].
    Aslan B; Izdeş S; Kesimci E; Gümüş T; Kanbak O
    Agri; 2009 Jan; 21(1):22-8. PubMed ID: 19357997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
    Geddoa E; Balakumar AK; Paes TR
    Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.
    Baumgartner FJ; Bertin S; Konecny J
    Ann Vasc Surg; 2009; 23(1):1-7. PubMed ID: 18619780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.
    Wehrmann T; Seifert H; Seipp M; Lembcke B; Caspary WF
    Endoscopy; 1998 Oct; 30(8):702-7. PubMed ID: 9865560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of palmar hyperhidrosis with botulinum toxin type A: 44 months of experience.
    Pérez-Bernal AM; Avalos-Peralta P; Moreno-Ramírez D; Camacho F
    J Cosmet Dermatol; 2005 Sep; 4(3):163-6. PubMed ID: 17129260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M; Silva S; Cottrell C
    Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Palmar and plantar hyperhidrosis: best practice recommendations and special considerations.
    Glaser DA; Hebert AA; Pariser DM; Solish N
    Cutis; 2007 May; 79(5 Suppl):18-28. PubMed ID: 17596097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Botulinum toxin type A for the treatment of primary hyperhidrosis: a prospective study of 52 patients].
    Martí N; Ramón D; Gámez L; Reig I; García-Pérez MA; Alonso V; Jordá E
    Actas Dermosifiliogr; 2010 Sep; 101(7):614-21. PubMed ID: 20858387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy of hypnosis in the treatment of palmar hyperhidrosis with botulinum toxin type A].
    Maillard H; Bara C; Célérier P
    Ann Dermatol Venereol; 2007; 134(8-9):653-4. PubMed ID: 17925688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
    Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
    Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.